CardioMEMS

company

About

CardioMEMS develops wireless sensing and communication technology solutions for severe chronic cardiovascular diseases in the human body.

  • 101 - 250

Details

Last Funding Type
Series F
Last Funding Money Raised
$22.10M
Industries
Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2001
Number Of Employee
101 - 250
Operating Status
Close

CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$82.58M
CardioMEMS has raised a total of $82.58M in funding over 2 rounds. Their latest funding was raised on May 10, 2010 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 10, 2010 Series Unknown $37.88M 2 Detail
Oct 9, 2009 Series F $22.10M 2 Detail
Nov 4, 2006 Series D $22.60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
CardioMEMS is funded by 2 investors. Medtronic and Rockport Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Medtronic Series Unknown
Rockport Venture Partners Series Unknown